Open AccessGlobe salvage treatment in group D and group E retinoblastoma
Author(s) -
Ahmad Khaqan Hussain,
Rachwani Anil Rahul,
Rocha de Lossada Carlos,
Zamorano Martín Francisco,
García Lorente María,
Flavia Pennisi,
Chiara Bocci,
Davide Borroni
Publication year - 2021
Publication title -
romanian journal of ophtalmology
Language(s) - English
Resource type - Journals
eISSN - 2501-2533
pISSN - 2457-4325
DOI - 10.22336/rjo.2021.5
Subject(s) - medicine , enucleation , retinoblastoma , cryotherapy , ophthalmology , surgery , biochemistry , chemistry , gene
Importance: Globe salvage marks the treatment success of retinoblastoma. Background: To evaluate four treatment strategies in group D and group E retinoblastoma. Design: Retrospective case series in a tertiary hospital. Participants: 81 patients with Group D and Group E retinoblastoma. Methods: Participants were divided into four sets. In set I, eyes received primary intravenous chemotherapy (IVC), cryotherapy (CT), laser therapy (LT) and Intravitreal Chemotherapy with Melphalan (IViC). In set II, primary IVC was combined with second line IVC, CT, LT and IVT-M. Set III eyes received primary IVC and Intra-arterial chemotherapy (IAC), CT, LT and IViC. Set IV eyes received IAC, CT, LT and IViC. Treatment failure was defined as inadequate response during or after IVC or IAC. Main Outcome Measures: globe salvage and enucleation rates. Results: 52 eyes were included in group D and 29 in group E. In group D, globe salvage was obtained in 8 out of 11 eyes in Set I, 13 out of 19 eyes in set II, 5 out 6 eyes in set III, and 13 out of 16 eyes in set IV. In group E, enucleation was performed in 17 eyes. Global salvage was obtained in 0 out of 2 eyes in set I, 2 out of 3 eyes in set II, 3 out of 5 in set III, and in 1 out of 2 eyes in set IV. Conclusions: IVC with adjuvant IAC, LT, CT and IViC has shown favorable results as a treatment method for group D and group E retinoblastoma.